← Patent-cliff monitor small molecule PONVORY PONESIMOD
Loss of exclusivity December 2044 latest FDA-listed patent expiry
Drug detail Brand name PONVORY Active ingredient PONESIMOD Strength 2MG; 3MG; 4MG; 5MG; 6MG; 7MG; 8MG; 9MG; 10MG Dosage form TABLET Route ORAL Modality Small molecule FDA approval March 2021 Marketing status RX
Listed patents Patent Expires Type 12728116 December 2044 use U-4610 11951097 October 2042 use U-3891 12336980 December 2035 use U-3103 10220023 December 2035 use U-3103 9062014 May 2032 substance, product RE43728 November 2029 substance, product
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.